Results 171 to 180 of about 12,593 (182)

Pirfenidone: A Review of Its Use in Idiopathic Pulmonary Fibrosis

Drugs, 2015
Esther S Kim
exaly  

Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions

Respirology, 2017
Huaqing Zhao, Gerard J Criner, Jonathan A Galli   +2 more
exaly  

Functionalized graphene oxide as a drug carrier for loading pirfenidone in treatment of subarachnoid hemorrhage

Colloids and Surfaces B: Biointerfaces, 2015
Gengshen Zhang
exaly  

Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy

Biopharmaceutics and Drug Disposition, 2015
Yukimune Kanehira, Kohei Togami
exaly  

Effects of Pirfenidone on Proliferation, Migration, and Collagen Contraction of Human Tenon’s Fibroblasts In Vitro

Investigative Ophthalmology and Visual Science, 2009
Minbin Yu, Kaili Wu, Xianchai Lin
exaly  

Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats

British Journal of Pharmacology, 2002
Lindsay Brown, Andrew Fenning, Solomon B Margolin   +2 more
exaly  

Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis

Respirology, 2014
Carlo ALBERA, Ulrich Costabel, Paul W. Noble   +2 more
exaly  

A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-α at the translational level

European Journal of Pharmacology, 2002
Shoji Yamane
exaly  

A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.

American Journal of Respiratory Cell and Molecular Biology, 2017
Oliver Eickelberg, PD Dr. Claudia Staab-Weijnitz, Juergen Behr   +2 more
exaly  

Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study

Respiratory Medicine, 2017
Susumu Sakamoto, Kenta Furuya, Keishi Sugino   +2 more
exaly